← Open Payments lookup

DEANNE GARAY: Open Payments

NPI 1417356387 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$786 in 40 payments from 9 companies in 2025. Trend: 2023 $1,371 · 2024 $440 · 2025 $786

Food & beverage: $786
CompanyPaymentsAmount
ABBVIE INC.14$217
Janssen Pharmaceuticals, Inc6$148
Supernus Pharmaceuticals, Inc.4$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$79
Vanda Pharmaceuticals Inc.3$72
Takeda Pharmaceuticals U.S.A., Inc.3$60
Axsome Therapeutics, Inc.2$51
Otsuka America Pharmaceutical, Inc.3$51
Alkermes, Inc.1$25

Products named: VRAYLAR, Qelbree, INVEGA SUSTENNA, CAPLYTA, FANAPT, SPRAVATO, TRINTELLIX, Auvelity.

Industry payments across TX — which companies pay providers there.